实体肿瘤危重症患者的急性肾损伤
AKI独立预测因素包括SAPS II评分、腹盆腔肿瘤、近3个月肾毒性化疗和脓毒症;但AKI并非短期死亡率的独立危险因素。
要点
- 实体肿瘤ICU患者AKI发生率高(59%),脓毒症是最常见诱因(80%)。
- 近3个月肾毒性化疗、腹盆腔肿瘤、脓毒症及高SAPS II评分独立预测AKI。
- AKI严重程度与90天肾脏恢复呈负相关,但AKI未独立增加短期死亡率。
核心结论
- 实体肿瘤危重症患者AKI常见,肾脏恢复随AKI严重程度逐渐降低,但AKI并非短期死亡的独立危险因素。
主要发现
- AKI发生率为59%,主要与脓毒症(80%)、低血容量(40%)和流出道梗阻(17%)相关。
- 12%患者接受肾脏替代治疗,住院死亡率为39%。
- AKI独立预测因素:SAPS II(OR 1.05;95%CI 1.02-1.07;P<0.001)、腹盆腔肿瘤(OR 2.84;95%CI 1.35-5.97;P=0.006)、近3个月肾毒性化疗(OR 3.84;95%CI 1.67-8.84;P=0.002)、脓毒症(OR 2.74;95%CI 1.30-5.77;P=0.008)。
- 90天肾脏恢复与AKI严重程度呈负相关。
- ICU、住院和90天死亡率分别为15%、29%和37%;ICU死亡独立相关因素为总血清蛋白(每10g/L,OR 0.44;95%CI 0.23-0.86;P=0.02)和SAPS II(OR 1.04;95%CI 1.01-1.07;P=0.02);90天死亡相关因素为体能状态3-4(OR 6.59;95%CI 2.42-18;P<0.001)和总血清蛋白(OR 0.60;95%CI 0.38-0.94;P=0.02)。
临床怎么用
- 对实体肿瘤ICU患者应警惕AKI,尤其合并脓毒症、腹盆腔肿瘤或近期肾毒性化疗者。
- 监测AKI严重程度有助于评估90天肾脏恢复前景。
- AKI并非短期死亡的独立预测因素,死亡风险评估需结合SAPS II、血清蛋白和体能状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with solid tumours are at risk for acute kidney injury (AKI), however, epidemiological data are limited. METHODS: We conducted a study that included patients with solid tumours admitted to a single-centre intensive care unit (ICU) from January 2011 to December 2015. We analysed factors associated with the occurence of AKI, ICU and Day-90 mortality. RESULTS: Two-hundred and four patients were included. The incidence of AKI was 59%, chiefly related to sepsis (80%), hypovolaemia (40%) and outflow tract obstruction (17%). Renal replacement therapy was implemented in 12% of the patients, with a hospital mortality of 39%. Independent predictors of AKI were: Simplified Acute Physiological Score II (SAPS II) [odds ratio (OR) 1.05; 95% confidence interval (95% CI) 1.02-1.07; P < 0.001], abdominal or pelvic cancer (OR 2.84; 95% CI 1.35-5.97; P = 0.006), nephrotoxic chemotherapy within the previous 3 months (OR 3.84; 95% CI 1.67-8.84; P = 0.002) and sepsis (OR 2.74; 95% CI 1.30-5.77; P = 0.008). Renal recovery at Day 90 was inversely related to AKI severity. ICU, hospital and Day-90 mortality were 15, 29 and 37%, respectively. Factors independently associated with ICU mortality were: total serum protein (OR per 10 g/L, 0.44; 95% CI 0.23-0.86; P = 0.02) and SAPS II (OR 1.04; 95% CI 1.01-1.07; P = 0.02), while Day-90 mortality was associated with performance status 3-4 (OR 6.59; 95% CI 2.42-18; P < 0.001) and total serum protein (OR 0.60; 95% CI 0.38-0.94; P = 0.02). CONCLUSIONS: AKI in patients with solid tumours was frequent and renal recovery gradually decreased in proportion to AKI severity. However, AKI was not independently associated with a higher short-term mortality.
引用
- Kemlin D, Biard L, Kerhuel L, et al. Acute kidney injury in critically ill patients with solid tumours. Nephrol Dial Transplant. 2018. PMID: 29579262. doi:10.1093/ndt/gfy051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。